Athersys, Inc. is a biotechnology company, which focuses on the field of regenerative medicine. It engages in the discovery and development of therapies designed to extend and enhance the quality of human life. The firm offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Athersys Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Athersys Inc market cap is $100.00.
What is the 52-week high for Athersys Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Athersys Inc 52 week high is $0.001 as of September 07, 2025.
What is the 52-week low for Athersys Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Athersys Inc 52 week low is $0.00 as of September 07, 2025.
What is the 50-day moving average of Athersys Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Athersys Inc 50-day moving average is $0.00.